20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.

On January 14, 2016, 20/20 GeneSystems, Inc. closed the transaction. The company has received $4,500,000 in funding. The company issued series A common share.

The transaction is led by new investor, Ping An Ventures and included participation from several family offices, and individual investors including individual investors affiliated with the Keiretsu Forum. The company has received $2,513,413 from 66 investors.